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Problem Identification
◦ Shingrix vaccine is in a shortage across the United States, including St. Albans and parts of
Franklin County. [1]
◦ Often patients complain of their inability to acquire the vaccine during regular appointments
at NOTCH. Although they have a prescription, pharmacies lack a sufficient quantity of Shingrix
Vaccine and waitlists for the vaccine become long, leaving patients waiting several months.
◦ The purpose of this project is to identify the shortage of the new Shingrix vaccine in St.
Albans, Vermont. This will provide patients with helpful information on how to acquire the
new vaccine the quickest way possible.

Problem Identification (cont.)
◦ This is a problem for the St Albans community because Shingrix is significantly more effective
than Zostavax as the old vaccinations efficacy wanes with time and advanced age. [2]
◦ Shingrix vaccine can be given to immunocompromised patients as it is an inactivated vaccine,
whereas the Zostavax vaccine is a live virus vaccine. It’s also significantly more effective. [3]
◦ Patients who don’t report a past episode of varicella should still receive the Shingles Vaccine
if they are older than 50. [3]

Public health cost

15.6% of people in St
Albans are over the age
of 65 (age 50 being the
age the CDC
recommends to start
vaccination). [2]

1 out of 3 people will
have a shingles outbreak
in their lifetime. [4]

10-15% of patients who
have an episode of
shingles will experiences
symptoms of
postherpetic neuralgia.
[4]

The annual health care
cost of treating herpes
zoster is $1.1 billion in
the United States, with
patients over 50 years
old being the most
effected population. [6]

Intervention and Methodology
◦ Pharmacies will be contacted around St. Albans and Franklin county to identify the shortage
and wait time for patients to receive the Shingrix vaccine. Information on how to acquire the
vaccine most effectively will be collected and given to patients.
◦ A handout containing evidence-based information and scholarly journal articles providing
information about Shingrix vaccine and its benefits vs Zostavax.
◦ Because vaccination recommendations start at age 50, a handout will be more helpful for
some patients who aren’t familiar with using the internet to filter information.

Community Perspective on Issue and Support for
Project
◦ Matt (PharmD) is a pharmacist in St. Albans. He states there’s a shortage of Shingrix because of back order on the
vaccine. He states at his pharmacy in St. Albans, they reserve 2 doses of the vaccine for each patient, so they don’t
need to be placed on a second wait list after their first dose. He states his current wait list is 22 people and none can
receive the vaccine at the moment because shipment is only available in bulk order. He recommends patients call
weekly to their pharmacy to see if their stocked, and getting their names onto the waitlist as early as possible.
◦ Allison (pharmacy technician) says at her pharmacy in St. Albans orders as much Shingrix vaccine as they’re allowed
too. They prioritize patients based on medical reasons. Those patients who need the vaccine are put at the beginning
of the list. Patients who are waitlisted for a second dose are also prioritized over patients who are receiving their first
dose. She states the current wait list at her establishment is 100+ patients.
◦ Jesse (Pharmacy technician) says patients at his pharmacy only have 10 days to receive their vaccine after they are
called from the waitlist. If they don’t arrive within 10 days, they lose their spot on the wait list. This can cause an
issue for patients with
◦ Sam (PharmD) states that at his pharmacy in St. Albans, they receive Shingrix from other regional stores. Because of
this, they have no waitlist. He recommends calling multiple locations before putting ones name on a waitlist to obtain
the vaccine the quickest.

Results/Response Data
Tips to obtain the Shingrix Vaccine quickly in St. Albans:
◦ Call your pharmacy and ask if they have the vaccine in stock. If not stocked, secure a place on the waitlist or
try calling other pharmacies.
◦ Obtain first and second doses at the same facility. Patients receiving their second dose have a higher priority
on the waitlist after receiving their first dose; some pharmacies will reserve your second dose.
◦ Call your insurance provider; ask if they cover the vaccine. Medicare part D covers the cost of the vaccine or
you may be eligible to be reimbursed based on your insurance provider, whereas Medicare part B does not
cover the cost. [3]
◦ Letting patients know they should receive the Shingrix Vaccine even if they have already gotten the Zostavax
(although they should wait at least 8 months before receiving Zostavax before receiving Shingrix). CDC reports
Shingrix being 97% effective after 2 doses, and reports Zostavax vaccine as only 51% effective. [3]
◦ If you have an underlying medical condition is present, consult a physician to increase your chances of
receiving higher priority for the vaccination. [3]

Evaluation of effectiveness and limitations
◦ Not all patients who receive healthcare from NOTCH live within a 15 mile radius, which is location the
pharmacies in this project were contacted.
◦ The handout from this project was only distributed to NOTCH clinic. Only patients receiving health care
from this practice have access to the handout.
◦ Some pharmacies have a policy where patients must get their shot within 10 days of receiving a phone
call from the wait list. If the patient does not arrive, they lose their opportunity to receive the vaccine.
Many of these patients live in places without reliable public transportation, don’t drive, or have trouble
transporting themselves.
◦ Shingrix is a 2-part shot, so patients should be reminded to return after their first dose. (2-6 months
after the first dose) [5]

◦ Not all patients will ask for information about the Shingrix Vaccine.

Recommendations for future interventions/projects
◦ Creation of a list with restocking dates of vaccine in St. Albans pharmacies.
◦ Adding to the NOTCH EMR a notification for providers to offer vaccine to patients over 50.
◦ Prioritizing pharmacies in the EMR based on vaccine availability.
◦ Collect information about the vaccine shortage in other neighboring counties.
◦ Creation of a log with updated pharmacy policies and information regarding vaccine distribution frequency.
◦ See research from other states where shortage was recorded and their responses to it.
◦ Interview patients to better understand their needs in obtaining the vaccine including the patient’s
perspective and their understanding of the virus.
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Consent Form
Thank you for agreeing to be interviewed. This project is a requirement for the
Family Medicine clerkship. It will be stored on the Dana Library ScholarWorks
website. Your name will be attached to your interview and you may be cited

directly or indirectly in subsequent unpublished or published work. The
interviewer affirms that he/she has explained the nature and purpose of this
project. The interviewee affirms that he/she has consented to this interview.

Consented: Yes (Verbally consented over the phome)

Name: _____Matt_________________________________________________________

Name: _____Allison_________________________________________________________

Name: _____Jesse_________________________________________________________

Name: _____Sam_________________________________________________________

